Jun-ping Shi
Impact in
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- Hepatology top 5%
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Epidemiology 122
- Liver Disease Diagnosis and Treatment 108
- Hepatitis B Virus Studies 19
- Hepatology 20
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Liver physiology and pathology 6
- Liver Disease and Transplantation 4
- Liver Diseases and Immunity 4
- Co-authors
- Jian-Gao Fan (18 shared papers)Lungen Lu (7 shared papers)You Ming Li (2 shared papers)Shufei Zang (15 shared papers)Jin Yang (9 shared papers)Yan Luo (15 shared papers)Yunhao Xun (15 shared papers)Jidong Jia (3 shared papers)
- Journals
- Journal of Hepatology (5 papers)Clinical and Experimental Pharmacology and Physiology (4 papers)Advances in Therapy (3 papers)Scientific Reports (3 papers)Hepatology (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Jun-ping Shi
164 papers receiving 3.8k citations
Jun-ping Shi's Hit Papers
Peers
Comparison fields: 5 of 108
- Epidemiology 2.2k
- Hepatology 277
- Cancer Research 208
- Biological Psychiatry 20
- Genetics 97
Countries citing papers authored by Jun-ping Shi
This map shows the geographic impact of Jun-ping Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-ping Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-ping Shi more than expected).
Fields of papers citing papers by Jun-ping Shi
This network shows the impact of papers produced by Jun-ping Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-ping Shi. The network helps show where Jun-ping Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun-ping Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects Hit paper breakdown → | 2021 | 252 |
| 2 | 2010 | 249 | |
| 3 | 2010 | 211 | |
| 4 | 2016 | 171 | |
| 5 | 2017 | 141 | |
| 6 | 2019 | 123 | |
| 7 | 2015 | 121 | |
| 8 | 2022 | 96 | |
| 9 | 2008 | 94 | |
| 10 | 2020 | 91 | |
| 11 | 2022 | 79 | |
| 12 | 2015 | 78 | |
| 13 | 2014 | 70 | |
| 14 | 2015 | 67 | |
| 15 | 2013 | 65 | |
| 16 | Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice. | 2019 | 63 |
| 17 | 2016 | 54 | |
| 18 | 2017 | 53 | |
| 19 | 2016 | 47 | |
| 20 | 2020 | 46 |
About Jun-ping Shi
Jun-ping Shi is a scholar working on Epidemiology, Hepatology, Molecular Biology, Pathology and Forensic Medicine and Cancer Research, having authored 178 papers that have together received 3.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (108 papers), Hepatitis B Virus Studies (19 papers), Gut microbiota and health (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver physiology and pathology (6 papers), Alcohol Consumption and Health Effects (5 papers), Liver Disease and Transplantation (4 papers) and Liver Diseases and Immunity (4 papers). The work is most often cited by research in Epidemiology (2.2k citations), Hepatology (277 citations), Cancer Research (208 citations), Biological Psychiatry (20 citations) and Genetics (97 citations). Jun-ping Shi has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Jian-Gao Fan, Lungen Lu, You Ming Li, Shufei Zang, Jin Yang, Yan Luo, Yunhao Xun, Jidong Jia, An‐Na Chen and Wenjun Yang. Their work appears in journals such as Journal of Hepatology, Clinical and Experimental Pharmacology and Physiology, Advances in Therapy, Scientific Reports and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.